Laboratory Corp of America (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 981,100 | 532,300 | 598,100 | 647,300 | 369,400 |
| Receivables | 2,450,500 | 2,260,700 | 2,265,200 | 2,276,700 | 2,274,500 |
| Inventories | 497,700 | 534,700 | 521,500 | 508,100 | 488,300 |
| TOTAL | $4,558,800 | $4,020,500 | $4,078,800 | $4,087,200 | $3,789,700 |
| Non-Current Assets | |||||
| PPE Net | 3,065,500 | 3,081,500 | 3,112,800 | 3,133,800 | 3,090,800 |
| Investments And Advances | 146,600 | 153,900 | 168,200 | 160,400 | 168,000 |
| Intangibles | 10,591,300 | 10,385,500 | 10,253,700 | 10,045,500 | 9,908,300 |
| Other Non-Current Assets | 724,900 | 751,300 | 648,100 | 633,000 | 647,000 |
| TOTAL | $14,528,300 | $14,372,200 | $14,182,800 | $13,972,700 | $13,814,100 |
| Total Assets | $19,087,100 | $18,392,700 | $18,261,600 | $18,059,900 | $17,603,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 695,700 | 840,800 | 668,500 | 793,000 | 717,900 |
| Accrued Expenses | 851,900 | 847,800 | 878,000 | 835,800 | 770,400 |
| TOTAL | $2,641,000 | $2,823,500 | $2,629,200 | $2,716,800 | $2,064,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,833,700 | 5,084,600 | 5,082,500 | 5,077,300 | 5,568,700 |
| Deferred Revenues | 405,200 | 439,100 | 391,600 | 398,000 | 388,300 |
| Other Non-Current Liabilities | 1,365,000 | 1,347,100 | 1,346,800 | 1,372,600 | 1,208,400 |
| TOTAL | $7,717,500 | $6,949,400 | $6,935,500 | $6,870,400 | $7,231,800 |
| Total Liabilities | $10,358,500 | $9,772,900 | $9,564,700 | $9,587,200 | $9,296,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,000 | 82,400 | 82,900 | 83,100 | 83,700 |
| Common Shares | 7,400 | 7,500 | 7,500 | 7,500 | 7,600 |
| Retained earnings | 8,784,400 | 8,639,900 | 8,698,400 | 8,498,000 | 8,455,600 |
| Other shareholders' equity | -63,200 | -27,600 | -42,000 | -34,600 | -191,600 |
| TOTAL | $8,728,600 | $8,619,800 | $8,696,900 | $8,472,700 | $8,307,400 |
| Total Liabilities And Equity | $19,087,100 | $18,392,700 | $18,261,600 | $18,059,900 | $17,603,800 |